Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The com… Read more
Fisher & Paykel Healthcare Corporation Limited (FSPKF) - Total Assets
Latest total assets as of March 2025: $2.55 Billion USD
Based on the latest financial reports, Fisher & Paykel Healthcare Corporation Limited (FSPKF) holds total assets worth $2.55 Billion USD as of March 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Fisher & Paykel Healthcare Corporation Limited - Total Assets Trend (2000–2025)
This chart illustrates how Fisher & Paykel Healthcare Corporation Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Fisher & Paykel Healthcare Corporation Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Fisher & Paykel Healthcare Corporation Limited's total assets of $2.55 Billion consist of 36.7% current assets and 63.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 10.4% |
| Accounts Receivable | $304.60 Million | 11.9% |
| Inventory | $342.90 Million | 13.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $82.10 Million | 3.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Fisher & Paykel Healthcare Corporation Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Fisher & Paykel Healthcare Corporation Limited's current assets represent 36.7% of total assets in 2025, a decrease from 48.2% in 2000.
- Cash Position: Cash and equivalents constituted 10.4% of total assets in 2025, up from 0.6% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 13.4% of total assets.
Fisher & Paykel Healthcare Corporation Limited Competitors by Total Assets
Key competitors of Fisher & Paykel Healthcare Corporation Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Fisher & Paykel Healthcare Corporation Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Fisher & Paykel Healthcare Corporation Limited generates 0.50x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Fisher & Paykel Healthcare Corporation Limited generates $ 14.79 in net profit.
Fisher & Paykel Healthcare Corporation Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.87 | 1.83 | 1.55 |
| Quick Ratio | 1.18 | 1.00 | 1.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $435.00 Million | $ 319.90 Million | $ 184.10 Million |
Fisher & Paykel Healthcare Corporation Limited - Advanced Valuation Insights
This section examines the relationship between Fisher & Paykel Healthcare Corporation Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.75 |
| Latest Market Cap to Assets Ratio | 3.87 |
| Asset Growth Rate (YoY) | 11.8% |
| Total Assets | $2.55 Billion |
| Market Capitalization | $9.88 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Fisher & Paykel Healthcare Corporation Limited's assets at a significant premium ( 3.87x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Fisher & Paykel Healthcare Corporation Limited's assets grew by 11.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Fisher & Paykel Healthcare Corporation Limited (2000–2025)
The table below shows the annual total assets of Fisher & Paykel Healthcare Corporation Limited from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $2.55 Billion | +11.79% |
| 2024-03-31 | $2.28 Billion | +3.50% |
| 2023-03-31 | $2.20 Billion | +4.63% |
| 2022-03-31 | $2.11 Billion | +1.54% |
| 2021-03-31 | $2.08 Billion | +44.60% |
| 2020-03-31 | $1.44 Billion | +14.16% |
| 2019-03-31 | $1.26 Billion | +15.61% |
| 2018-03-31 | $1.09 Billion | +13.66% |
| 2017-03-31 | $956.62 Million | +12.41% |
| 2016-03-31 | $850.97 Million | +25.62% |
| 2015-03-31 | $677.42 Million | -0.23% |
| 2014-03-31 | $678.97 Million | -11.89% |
| 2013-03-31 | $770.60 Million | +6.17% |
| 2012-03-31 | $725.82 Million | +3.50% |
| 2011-03-31 | $701.26 Million | +13.58% |
| 2010-03-31 | $617.39 Million | +21.84% |
| 2009-03-31 | $506.72 Million | +31.45% |
| 2008-03-31 | $385.50 Million | +24.08% |
| 2007-03-31 | $310.69 Million | -0.42% |
| 2006-03-31 | $312.01 Million | +24.58% |
| 2005-03-31 | $250.45 Million | -3.07% |
| 2004-03-31 | $258.37 Million | +2.73% |
| 2003-03-31 | $251.51 Million | -3.53% |
| 2002-03-31 | $260.70 Million | -8.68% |
| 2001-03-31 | $285.47 Million | -37.84% |
| 2000-03-31 | $459.22 Million | -- |